- Home
- INVA vs KBDC Comparison
INVA vs KBDC Comparison
Compare INVA & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- KBDC
- Stock Information
- Founded
- INVA 1996
- KBDC 2021
- Country
- INVA United States
- KBDC United States
- Employees
- INVA N/A
- KBDC N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- KBDC
- Sector
- INVA Health Care
- KBDC
- Exchange
- INVA Nasdaq
- KBDC Nasdaq
- Market Cap
- INVA 1.2B
- KBDC 1.2B
- IPO Year
- INVA 2004
- KBDC N/A
- Fundamental
- Price
- INVA $21.58
- KBDC $15.89
- Analyst Decision
- INVA Buy
- KBDC Buy
- Analyst Count
- INVA 1
- KBDC 5
- Target Price
- INVA $55.00
- KBDC $16.60
- AVG Volume (30 Days)
- INVA 815.1K
- KBDC 120.9K
- Earning Date
- INVA 07-30-2025
- KBDC 05-12-2025
- Dividend Yield
- INVA N/A
- KBDC 11.96%
- EPS Growth
- INVA N/A
- KBDC N/A
- EPS
- INVA N/A
- KBDC N/A
- Revenue
- INVA $369,844,000.00
- KBDC N/A
- Revenue This Year
- INVA $3.75
- KBDC $193.84
- Revenue Next Year
- INVA $12.62
- KBDC $12.68
- P/E Ratio
- INVA N/A
- KBDC N/A
- Revenue Growth
- INVA 18.70
- KBDC N/A
- 52 Week Low
- INVA $15.56
- KBDC $13.93
- 52 Week High
- INVA $21.60
- KBDC $17.99
- Technical
- Relative Strength Index (RSI)
- INVA 86.95
- KBDC N/A
- Support Level
- INVA $18.59
- KBDC N/A
- Resistance Level
- INVA $19.08
- KBDC N/A
- Average True Range (ATR)
- INVA 0.42
- KBDC 0.00
- MACD
- INVA 0.25
- KBDC 0.00
- Stochastic Oscillator
- INVA 99.35
- KBDC 0.00
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.